Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Access to genomic testing, not therapy cost, is the biggest challenge
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
Subscribe To Our Newsletter & Stay Updated
